Results 191 to 200 of about 21,216 (279)

Correction: Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. [PDF]

Paediatr Drugs
Kamphuis AEM, Bamford A, Tagarro A, Cressey TR, Bekker A, Amuge P, Mujuru HA, Ndongo FA, Diack A, Compagnucci A, Lallemant M, Colbers A, Turkova A.   +12 more
europepmc   +1 more source

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

, 2010
Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, Ellen S. Chan, David M. Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, Ann Wiegand, Mary F. Kearney, John M. Coffin, John W. Mellors, Joseph J. Eron   +16 more
openalex   +2 more sources

How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy? [PDF]

J Antimicrob Chemother
Gilbert M, Ferré VM, Guilbaud R, Digumber M, Peytavin G, Damond F, Le Hingrat Q, Yazdanpanah Y, Descamps D, Charpentier C, Joly V, Ghosn J.   +11 more
europepmc   +1 more source

Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients [PDF]

, 2015
Bangham, C, Cook, LBM, De Freitas,, D, Demontis, MA, Fox,, J, Laydon, D, Martin,, F, Medcalf,, J, Melamed, A, Neuberger, J, Price,, A, Taylor, G, Tosswill, J   +12 more
core   +1 more source

Raltegravir in the Treatment of HIV–2 Infection: A Report of Eight Cases

, 2015
Diana Póvoas, Sara Lino, Maria José Manata, João Machado, Fernando Maltêz   +4 more
openalex   +2 more sources

Breastfeeding on ART and a closer look at drug transfer to HIV-exposed uninfected infants. [PDF]

Sci Rep
Spielberger BD, Zink A, Rohr JC, Usadel S, Klinker H, Freudenhammer M, Elling R, Rieg S, Henneke P, Hufnagel M, Müller MC.   +10 more
europepmc   +1 more source

National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing. [PDF]

J Antimicrob Chemother
Martínez-Buitrago E, Zapata-Marín AF, Rubiano LC, Sañudo LM, Oñate JM, Lenis W, García-Góez JF, Álvarez JE, García-Morales C, Matías-Florentino M, Ávila-Ríos S.   +10 more
europepmc   +1 more source

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study. [PDF]

EClinicalMedicine
Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Dos Santos Mendes S, Tallada J, Kowalska J, Wallner E, Kusejko K, Jaschinski N, Lundgren J, Peters L, Reekie J.   +23 more
europepmc   +1 more source

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus–Infected Patients With Nonalcoholic Fatty Liver Disease

Clinical Infectious Diseases, 2017
J. Macías, M. Mancebo, D. Merino, F. Téllez, M. L. Montes-Ramírez, F. Pulido, A. Rivero-Juarez, M. Raffo, M. Pérez-Pérez, N. Merchante, M. Cotarelo, J. Pineda, L. M. Real, Fernando Saussol, J. Romero, I. Suárez, Francisco J Martínez, José M Fajardo, F. Rodríguez-Gómez, S. Lorenzo-Moncada, José Carlos Roldán Morales, Estefanía Santolo, M. Castro-García, Juan R. González, M. Lagarde, M. Matarranz, O. Bisbal, R. Rubio, Á. Camacho, I. Machuca, A. Rivero   +30 more
semanticscholar   +1 more source

Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil? [PDF]

Rev Paul Pediatr
Costa SMD, Aguiar PM.
europepmc   +1 more source